United States Antithrombin Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | CSL Limited, Grifols SA, Octapharma AG, Lee Biosolutions Inc and BDI Pharma

Antithrombin Market reached USD 545 million in 2022 and is projected to witness lucrative growth by reaching up to USD 775.7 million by 2030. The Global Antithrombin Market is expected to exhibit a CAGR of 4.6% during the forecast period 2023-2030.

DataM Intelligence has published a new research report on "Antithrombin Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/antithrombin-market?sg

Key Players: CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc, Siemens AG, Thermo Fisher Scientific, Lee Biosolutions Inc and BDI Pharma.

United States - Industry Developments:

✅ FDA Approval of QfitliaTM (Fitusiran)
On March 28, 2025, the U.S. FDA approved QfitliaTM (fitusiran) for routine prophylaxis in hemophilia A or B patients aged 12 and older, with or without inhibitors.

✅ FDA Clearance for Innovance Antithrombin Assay
On March 28, 2025, Siemens Healthineers announced that its Innovance Antithrombin assay received FDA clearance as a companion diagnostic for QfitliaTM treatment.

Japan - Industry Developments:

✅ Phase III Study of ART-123 (RecomodulinTM)
On June 27, 2025, Asahi Kasei Pharma initiated a Phase III study of ART-123 (thrombomodulin alfa) for preventing chemotherapy-induced peripheral neuropathy.

✅ M&A Activity Involving Ayumi Pharmaceutical
On September 30, 2025, Ayumi Pharmaceutical, Japan's leading pharmaceutical company, was reported to be seeking a new owner in Korea, with Blackstone aiming to recover its investment.

South Korea - Industry Developments:

✅ Ayumi Pharmaceutical's Potential Sale
On September 30, 2025, Ayumi Pharmaceutical, Japan's leading pharmaceutical company, was reported to be seeking a new owner in Korea, with Blackstone aiming to recover its investment.

✅ Celltrion's Strategic Inventory Management
On May 9, 2025, Celltrion announced measures to minimize tariff impacts by adjusting inventory strategies, aiming to mitigate potential challenges in the first half of the following year.

Europe - Industry Developments:

✅ Ethypharm's Acquisition of Argatroban Business
On June 17, 2024, Ethypharm entered into an agreement with Mitsubishi Tanabe Pharma Corporation to acquire the selective antithrombin agent, Argatroban monohydrate, in Europe

Growth Forecast Projected:

The Global Antithrombin Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Antithrombin Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=antithrombin-market?sg

Key Segments:

By Usage (Therapeutics, Diagnostics, Research, Other)

By Type (Anticoagulant, Antiplatelet, Thrombolytic Drug)

By Route of Administration (Oral, Parenteral)

By Source (Human, Recombinant Goat milk, Others)

By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Antithrombin producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Antithrombin revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antithrombin-market?sg

FAQ's

Q1: What is the current size of the Antithrombin Market?

A: The Antithrombin Market stood at USD 545 million in 2022 and is set to experience remarkable growth, reaching USD 775.7 million by 2030

Q2: How fast is the Antithrombin Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 4.6% from 2025 to 2032

Q3: Which regions are dominating the Antithrombin Market and which are fastest-growing?

A: North America holds a dominant position in the global antithrombin market.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/antithrombin-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.